Thrombocytopenia and increased risk of adverse outcome in COVID-19 patients

Thrombocytopenia and increased risk of adverse outcome in COVID-19 patients

Background Thrombocytopenia was common in the coronavirus disease 2019 (COVID-19) patients during the infection, while the role of thrombocytopenia in COVID-19 pathogenesis and its relationship with systemic host response remained obscure. The study aimed to systematically evaluate the relationship...

Full description

Bibliographic Details
Main Authors: Yang Yuan, Gang Wang, Xi Chen, Xiao-Lei Ye, Xiao-Kun Li, Rui Li, Wan-Li Jiang, Hao-Long Zeng, Juan Du, Xiao-Ai Zhang, Hao Li, Li-Qun Fang, Qing-Bin Lu, Wei Liu
Format: Article
Language:English
Published: PeerJ Inc. 2022-06-01
Series:PeerJ
Subjects:
Thrombocytopenia
COVID-19
Adverse outcome
Mortality
China
Online Access:https://peerj.com/articles/13608.pdf

Internet

https://peerj.com/articles/13608.pdf

Similar Items